Today on DrugResearcher.com   New schizophrenia target found in the glutamate system Merck failure not our fault, says Crucell IOTA breaks into fragment-based screening field Plexera and MitoSciences to develop ADME/Tox arrays Wyatt lights up protein aggregation

Related Industry News   Gerresheimer gets pat on the back for packaging concept Ventana continues to brush off Roche's advances US firm launches online patient recruitment tool Indian manufacturers need to lose generic mindset

Breaking News on Drug Discovery
Daily  Wednesday 26 September 2007		Forward to a colleague

	Company Profile CHIRALPAK® IC CHIRAL TECHNOLOGIES EUROPE announce the launch of CHIRALPAK® IC. The combination of CHIRALPAK® IA , IB and now IC provides a screening set of columns with exceptionally high success rates. The chiral separation of > 99% of all small molecules is attained using just 3 columns and four mobile phase combinations... Click Here Access Full Stories New schizophrenia target found in the glutamate system US researchers have published new results that indicate the metabotropic glutamate 5 receptor (mGluR5) could be a potential target for new schizophrenia therapies... Read Merck failure not our fault, says Crucell Dutch firm Crucell is hastily trying to reassure investors that its popular cell line technology, PER.C6, was not to blame for the failure of Merck's hotly touted HIV vaccine last week... Read IOTA breaks into fragment-based screening field A new player, IOTA Pharmaceuticals, has entered the fragment-based drug discovery (FBDD) services arena this week. ... Read Plexera and MitoSciences to develop ADME/Tox arrays Plexera and MitoSciences will collaborate to commercialise an antibody array designed to study mitochondrial function that could become an integral part of ADME/Tox (absorption, distribution, metabolism, excretion... Read Wyatt lights up protein aggregation Wyatt Technologies has launched a new instrument that automates protein aggregation measurement for use in all areas of the pharmaceutical industry from drug development to quality control (QC)... Read
	All News Headlines for: September | August | July
	Technical / White Paper DeltaDOT label free analysis of biomolecules Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here
	Related Industry News Gerresheimer gets pat on the back for packaging concept German packaging company Gerresheimer has received recognition for its packaging expertise again after winning the German Packaging Award the second year in a row... Read Ventana continues to brush off Roche's advances Roche's latest takeover bid extension has been brushed off by histopathology diagnostics expert Ventana as it believes 'it is worth significantly more' than the current $3bn (€2.1bn) offer... Read US firm launches online patient recruitment tool Californian marketing company BlueLithium has launched a new web-based solution to help pharma companies overcome the challenges of recruiting patients for clinical trials... Read Indian manufacturers need to lose generic mindset Indian drug manufacturers need to rid themselves of their generic mindset in order to evolve and remain competitive for the future... Read Inside India: special series Indian manufacturers need to lose generic mindset Indian drug manufacturers need to rid themselves of their generic mindset in order to evolve and remain competitive for the future. Read Sponsored Link DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here Previous Headlines BMS buys biologics partner, strengthens oncology Bristol-Myers Squibb (BMS) will pay up to $490m (€348m) for Adnexus Therapeutics, as it continues its transformation into a biopharmaceutical company and strengthens its oncology pipeline... Read ProImmune launches T cell antigen prediction assay ProImmune has launched a new cell-free assay for Class II HLA (human leukocyte antigen) that can help understand key helper T cell immune responses and aid the design of highly targeted therapies... Read New UK joint venture bets on membrane biology services A UK university and a British consultancy firm have teamed up to offer outsourced R&D services focused on membrane biology - an increasingly promising area of drug development... Read Innovation 'key' to India's pharma future The key to the future of India's pharmaceutical industry will depend on its ability to scale back its over-reliance on low-cost manufacturing and to foster innovation, with drug discovery and biosimilars presenting... Read Pfizer to spin off Japan drug research lab Pfizer is considering offers from investors in a bid to spin off its drug research and development laboratory in Japan and make it an independent entity, according to media reports... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com